Phenotypic and genotypic characteristics of Pseudomonas aeruginosa strains isolated from hospitals in the north-west region of Poland

Polish Journal of Microbiology

Volumn 55, Issue 2, 2006, Pages 103-112

  Czekajło Kołodziej, Urszula ^a,b   Giedrys Kalemba, Stefania ^a   Mȩdrala, Dagmara ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b WEST POMERANIAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Antibiotic resistance; Arbitrarily primed PCR (AP PCR); Fingerprinting; Nosocomial infections; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; CARBENICILLIN; CEFTAZIDIME; CETRIMIDE; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PEFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOTYPE; BLOOD GROUP TYPING; CONTROLLED STUDY; GENOTYPE; HUMAN; INTRASPECIFIC VARIATION; MOLECULAR PHYLOGENY; MORPHOLOGICAL TRAIT; NONHUMAN; PHENOTYPE; POLAND; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SEROTYPING;

CROSS INFECTION; DNA FINGERPRINTING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; POLAND; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEROTYPING;

PSEUDOMONAS AERUGINOSA;

EID: 33745947061     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ayats J., X. Corbella, C. Ardanuy, M.A. Dominguez, A. Ricart, J. Ariza, R. Martin and J. Linares. 1997. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J. Hosp. Infect. 37: 287-295.
2. Bertrand X., P. Bailly, G. Blasco, P. Bavay, A. Boillot and D. Talon. 2000. Large outbreak in a surgical intensive care unit colonization or infection with Pseudomonas aeruginosa that overexpressed an active efflux pump. Clin. Infect. Dis. 31: 9-14.
3. Biendo M., G. Laurans, J.F. Lefebvre, F. Daoudi and F. Eb. 1999. Epidemiological study of an Acinetobacter baumannii outbreak by using a combination of antibiotyping and ribotyping. J. Clin. Microbiol. 37: 2170-2175.
4. Bingen E., S. Bonacorsi, P. Rohrlich, M. Duval, S. Lhopital, N. Brahimi, E. Vilmer and R.V. Goering. 1996. Molecular epidemiology provides evidence of genotypic heterogeneity of miltidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital. J. Clin. Microbiol. 12: 3226-3229.
5. Boddie D.E., D.G. Currie, O. Eremin and D.S. Heys. 2003. Immune suppression and isolated severe head injury: a significant clinical problem. Brit. J. Neurosurg. 17: 405-417.
6. Bouza E., F. Garcia-Garrote, E. Cercenado, M. Marin and M.S. Diaz. 1999. Pseudomonas aeruginosa: a survery of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa study group. Antimicrob. Agents Chemother. 43: 981-982.
7. Cavallo J.D., F. Leblanc and R. Fabre. 2000. Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study. Pathol. Biol. 48: 472-477.
8. Cobb B.D. and J.M. Clarkson. 1992. Optimization of RAPD fingerprinting. In: M.R. Micheli, R. Bova (eds), Fingerprinting methods based on arbitrarily primed PCR. New York: Springer-Verlag. 93-102.
9. Czekajło-Kołodziej U. 2001. Phenotypic and genotypic characteristics of Pseudomonas aeruginosa i Acinetobacter baumannii isolated from hospitals in Szczecin (in Polish). Zakażenia 1: 35-37.
10. Dinesh S.D., H. Grundmann, T.L. Pitt and U. Romling. 2003. European-wide distribution of Pseudomonas aeruginosa clone C. Clin. Microbiol. Infect. 9: 1228-1233.
11. Dzierżanowska D. 1997. Antibiotic-resistant bacteria in hospital (in Polish). Nowa Med. 16: 18-24.
12. Fierobe L., J.C. Lucet, D. Decre, C. Muller-Serieys, A. Deleuze, M.L. Joly-Guillou, J. Mantz and J.M. Desmonts. 2001. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients. Infect. Control Hosp. Epidem. 22: 35-40.
13. Fiett J., K. Trzciński, W. Hryniewicz and M. Gniadkowski. 1998. The application of molecular biology methods in epidemiological typing of Pseudomonas aeruginosa isolated from hospital outbreak (in Polish). Przeg. Epidem. 52: 427-441.
14. Garcia-Garmendia J.L., C. Ortiz-Leyba, J. Garnacho-Montero, F.J. Jimenez-Jimenez, J. Monterrubio-Villar and M. Gili-Miner. 1999. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit. Care Med. 27: 1794-1799.
15. Garrouste-Orgeas M., O. Marie, M. Rou veau, S. Villiers, G. Arlet and B. Schlemmer. 1996. Secondary carriage with multi-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: relationship with nosocomial infections and mortality. J. Hosp. Infect. 34: 279-289.
16. Giedrys-Kalemba S. 2000. Antibiotic-resistance of bacteria isolated in the north-west region of Poland (in Polish). Przegl. Epidemiol. 54: 45-56.
17. Giedrys-Kalemba S., I. Bilska, T. Nikodemski, R. Bohatyrewicz and A. Kaczmarek. 2001. Microbiological assessment of materials from respiratory tract in patients requiring mechanical ventilation (in Polish). Zakażenia 1: 44-45.
18. Gillespie T.A., P.R.E. Johnson, A.W. Notman, J.E. Coia and M.F. Hanson. 2000. Eradication of resistant Pseudomonas aeruginosa strain after a cluster of infections in hematology/oncology unit. Clin. Microbiol. Infect. 6: 125-130.
19. Gomez P.J.C, W.L. Pedreira Jr., E.M. Araujo, F.G. Soriano, E.M.A. Negri, L. Tonangelo and I. Tadeu Velasco. 2000. Impact of BAL in the management of pneumonia with treatment failure: positivity of BAL culture under antibiotic therapy. Chest 118: 1739-1746.
20. Gospodarek E. and B. Waszak. 1995. Prevention against hospital outbreaks (in Polish). Med. 51/52: 10-13.
21. Habs I. 1957. Untersuchungen uber die O-Antigene von Pseudomonas aeruginosa. Zeitschr Hygiene 144: 218-228.
22. Hanberger H., M. Erlandsson, L.G. Burman, O. Cars, H. Gill, S. Lindgren, L.E. Nilsson, B. Olsson-Liljequist, S. Walter and ICU-STRAMA Study Group. 2004. High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility. Scand. J. Infect. Dis. 36: 24-30.
23. Hancock R.E.W., L.M. Mutharia, L. Chain, R.P. Darveau, D.P. Speert and G.B. Pïer. 1983. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 42: 170-177.
24. Jaworski A., P. Sta̧czek. 1993. Variability of bacterial genome (in Polish). Post. Mikrobiol. 32: 113-156.
25. Kang C.I., S.H. Kim, S.H. Kim, H.B. Kim, S.W. Park, Y.J. Choe, M.D. Oh, B.C. Kim and K.W. Choe. 2003. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin. Infect. Dis. 37: 745-747.
26. Kersulyte D., M.J. Struelens, A. Deplano and D.E. Berg. 1995. Comparision of arbitrarily primed PCR and macrorestriction (Pulsed-Field Gel Electroforesis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J. Clin. Microbiol. 33: 2216-2219.
27. Łopaciuk U. 1996. Strategies for limitation of resistant strains number (in Polish). Antybiotykoterapia i Choroby Infekcyjne 3: 621-624.
28. Nikodemski T. 1997. Ph.D. thesis. Pomeranian Medical University, Szczecin
29. Peacock S.J. and C.S. Garrard. 1997. The challenge of Pseudomonas aeruginosa pneumonia. Yearbook of Intensive Care and Emergency Medicine 1997. Berlin-Heidelberg: Springer-Verlag. 607-624.
30. Performance standards for antimicrobial susceptibility testing. Ninth Informational Supplement. January 1999. NCCLS M100-S8; M100-S9.
31. Piotrowska B. 1998. Pneumonia (in Polish). Nowa Klinika 5: 59-63.
32. Power E.G.M. 1996. RAPD typing in microbiology - a technical review. J. Hosp. Infect. 34: 247-265.
33. Sader H., M. Castanheira, R.E. Mendes, M. Toleman, T.R. Walsh and R.N. Jones. 2005. Dissemination and diversity of metallo-β-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int. J. Antimicrobiol. Agent 25: 57-61.
34. Spencer R.C. 1993. Nosocomial infection in the intensive care unit: a question of surveillance. Int. Care World 10: 173-176.
35. Struelenes M.J., V. Schwam, A. Deplano and D. Baran. 1993. Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibriosis patients. J. Clin. Microbiol. 31: 2320-2326.
36. Taguchi G. and Y. Wu. 1980. Introduction to off-line quality control. Nagoya: Japan Quality Control Organization.
37. van Belkum A. 1994. DNA fingerprinting of medically important microorganisms by use of PCR. Clin. Microbiol. Rev. 7: 174-184.
38. Versalovic J., C.R. Woods, P.R. Georghiou, R.J. Hamill and J.R. Lupski. 1993. DNA-based identification and epidemiologic typing of bacterial pathogens. Arch. Pathol. Lab. Med. 117: 1088-1098.